DSM acquires Pentapharm

DSM has acquired cosmetic active ingredient specialist Pentapharm.

Pentapharm, headquartered in Basel, Switzerland, with sales revenues of some E40 million, employs about 200 people at locations in Switzerland, Japan and Brazil.

Pentapharm holds a global leading position in the development and production of active ingredients and system solutions for the personal care industry and is also present in niche pharmaceutical and diagnostics markets. Pentapharm is particularly well known for its capabilities in innovation which have won it high regard among customers and strong brand recognition in the industry.

Pentapharm’s cosmetic active ingredients meet consumers’ increasing demand for effective anti-ageing, self-tanning, body-slimming and whitening products. Supported by the global wellness trend such cosmetic active ingredients benefit from the highest growth rates within the personal care ingredients market.

Latest Issues

Society of Cosmetic Chemists 78th Annual Scientific Meeting & Showcase

JW Marriot Los Angeles L.A. LIVE
11th - 13th December 2024

PCHi 2025

China Import and Export Fair Complex Guangzhou
19-21 February 2025